T1D

Related by string. T1 * * T1 E1 T3 E3 . CSU DSUs T1 CSUs . X.# T1 E1 T3 . T1 T2 . stages T1 T2 . T1 E1 fractional . Fractional T1 . DSC T1 . T1 E1 . UltraSPARC T1 . UltraSparc T1 . Caparo T1 . UltraSPARC T1 processor . DSL T1 . T1 T3 . UltraSparc T1 processor . Historically T1s . UltraSparc T1 Niagara . T1 E1 Analyzer . Covad T1 . networks T1 E1 . includes T1 E1 . T1 weighted . T1 circuits . T1 Income Tax *

Related by context. All words. (Click for frequent words.) 66 SSc 64 protein tyrosine phosphatase 63 HER2 overexpression 63 germline mutations 63 sporadic ALS 63 NF1 63 heterozygotes 62 PTPN# 62 BMPR2 62 Acute Myeloid Leukaemia AML 62 ABCB1 62 mutated K ras 62 Leukemias 61 ADPKD 61 GISTs 61 gene MECP2 61 metastatic neuroendocrine tumors 61 FLT3 61 euthymic patients 61 Leydig cell 61 vWD 61 diabetes mellitus DM 61 T1DM 61 GBA mutations 61 monogenic 61 IL#B 61 homozygotes 61 familial ALS 60 neurofibromatosis type 60 natriuretic peptide 60 familial hypercholesterolemia 60 K ras mutations 60 airway hyperresponsiveness 60 SMAD4 60 MLH1 60 pheochromocytoma 60 prostate cancer CaP 60 activating mutation 60 COX2 60 LHON 60 Severe Primary IGFD 60 microglial 60 T2DM 60 chromosomal rearrangement 60 PCa 60 artery stenosis 60 ependymoma 60 motor neuron diseases 60 pulmonary hypertension PH 60 hepatocellular carcinomas 60 microdeletions 60 IKZF1 60 monocytic 60 tyrosine phosphorylation 60 circadian genes 60 missense mutations 60 mRNA expression 60 IL 1ß 59 gene polymorphism 59 FTLD 59 chemokine receptor 59 inducible nitric oxide synthase 59 allelic variants 59 lung fibrosis 59 Notch1 59 TP# mutation 59 thyrotropin 59 proband 59 transgene expression 59 leukemia AML 59 HLA B# 59 KIF6 gene 59 NF2 59 chronic myeloid 59 neuroblastoma tumors 59 Chronic Fatigue Syndrome CFS 59 motor neuron degeneration 59 germline mutation 59 Alzheimers disease 59 beta amyloid peptides 59 Immunohistochemical analysis 59 MAPK pathway 59 glycated hemoglobin levels 59 pharmacologic intervention 59 AAT deficiency 59 Glioma 59 molecular abnormalities 59 BRAF V#E 59 urothelial carcinoma 59 hippocampal atrophy 59 LPS induced 59 MYH9 gene 59 breast carcinoma 59 Hcrt 59 CD# CD# 59 GLUT1 59 myeloproliferative disorders 59 CEACAM1 59 rs# [004] 59 PTEN mutations 59 nodal metastasis 59 malarial anemia 59 pancreatic adenocarcinoma 59 Protein Kinase C 59 lung adenocarcinoma 59 Niemann Pick disease 59 apoE4 59 alpha1 59 CDKN2A 59 interferon IFN 59 APOE e4 59 T#I [002] 59 CYP#C# gene 59 striatal dopamine 59 breast cancer subtypes 59 cyclin E 58 neovascularisation 58 APOE ε4 58 gastric adenocarcinoma 58 myeloproliferative 58 HLA DR4 58 prostate carcinoma 58 childhood leukemias 58 CTEPH 58 malignant lymphoma 58 58 Gleevec resistant 58 XLHED 58 PON1 58 PsA 58 Hemophilia B 58 hyperprolactinemia 58 myeloproliferative diseases 58 vWF 58 susceptibility gene 58 NMIBC 58 cystatin 58 intracranial hemorrhage ICH 58 homozygote 58 leukemia ALL 58 etiologic 58 IPAH 58 colorectal carcinoma 58 PBMCs 58 RAS mutations 58 p# activation 58 euthyroid 58 ZNF# 58 neurocognitive impairment 58 Ischemic 58 hyperparathyroidism 58 immunocompetent 58 HBeAg negative 58 hereditary hemochromatosis 58 KRAS mutations 58 NQO1 58 LRAT 58 miR #a [001] 58 #p#.# [002] 58 Sjögren syndrome 58 de novo mutations 58 Natalizumab 58 PAOD 58 tuberous sclerosis complex 58 mtDNA mutations 58 atypical hyperplasia 58 T2D 58 narcolepsy cataplexy 58 V#F mutation 58 syngeneic 58 beta1 integrin 58 octreotide LAR 58 astrocytomas 58 Lymphocytic 58 neovascular 58 Dysregulation 58 paragangliomas 58 cell adhesion molecule 58 CDH1 58 pDC 58 #q#.# [001] 58 complement inhibitor eculizumab 58 gastrointestinal stromal tumors GISTs 58 histologies 58 penetrance 58 TCF#L# 58 progressive neurodegenerative disorder 58 hypogonadotropic hypogonadism 58 GSTM1 58 FGFR4 58 cardiac allograft vasculopathy 58 ADAMTS# 58 RRM1 58 CC genotype 58 GSTP1 58 osteosarcomas 58 Oncogenic 58 HGPIN 58 ERBB2 58 prostate adenocarcinoma 58 Leber congenital amaurosis LCA 58 BMP2 58 angiographically 58 lymphoid cells 58 WT1 58 nonischemic 58 interleukin IL 58 ERK signaling 58 motoneurons 58 BRAF mutation 58 oligodendrogliomas 58 Trandolapril 58 Aortic stenosis 58 Polymorphism 58 systemic amyloidosis 58 lupus anticoagulant 58 homozygosity 58 fulminant hepatic failure 58 hyperplastic 58 MADRS score 58 NOMID 58 serum IGF 57 thyroid carcinoma 57 VCFS 57 MTHFR 57 leukaemias 57 Mutational 57 metastatic malignant 57 Subarachnoid hemorrhage 57 fronto temporal dementia 57 alpha1 antitrypsin deficiency 57 eIF 4E 57 chromosome #q# [001] 57 Nilotinib 57 KRAS oncogene 57 thrombotic complications 57 recurrent miscarriage 57 SHANK3 57 squamous cell lung cancer 57 CP CPPS 57 endocannabinoid signaling 57 serum urate levels 57 subclinical atherosclerosis 57 #p# [003] 57 VKORC1 57 renal fibrosis 57 seminomas 57 Activating mutations 57 Hp2 2 57 ß1 57 methylenetetrahydrofolate reductase 57 karyotypes 57 T2 lesions 57 atrophic gastritis 57 FGFR2 57 mTOR inhibitors 57 neurosensory 57 p# biomarker 57 gastric carcinoma 57 CIN2 + 57 neuropsychiatric disorder 57 HIV HCV coinfected 57 CD# expression [001] 57 CDK4 57 MECP2 gene 57 thrombocytosis 57 experimental autoimmune encephalomyelitis 57 lactate dehydrogenase LDH 57 renovascular hypertension 57 TMEM#B 57 thrombophilia 57 herpesviruses 57 KLF4 57 liver histology 57 CYP#C# [002] 57 CD#b 57 demyelinating 57 APOE4 57 thymosin 57 PARP inhibition 57 genetic variants associated 57 metabotropic glutamate receptors 57 EoE 57 RAS blockers 57 null mice 57 MMP# 57 gene locus 57 myelomeningocele 57 bladder carcinoma 57 relapsing multiple sclerosis 57 cryptogenic 57 5 HTTLPR 57 ALI ARDS 57 glutamatergic 57 MSH2 57 C#Y 57 atherothrombotic 57 sCJD 57 neuroinflammation 57 hamartomas 57 anthracycline chemotherapy 57 NNRTI resistance 57 SLC#A# [002] 57 membranous nephropathy 57 IFN γ 57 Bronchiectasis 57 effector function 57 Langerhans cell histiocytosis 57 basal cell carcinoma BCC 57 CD4 + CD# 57 Cytotoxic T 57 alexithymia 57 apolipoprotein E 57 myasthenia gravis MG 57 breast cancer metastasis 57 #q# deletion syndrome 57 acetylcholine receptor 57 TGF beta1 57 HNPCC 57 AAT Deficiency 57 plasmacytoid 57 bexarotene 57 astrocytic 57 malignant neoplasm 57 metaplasia 57 myeloproliferative neoplasms 57 congenital hyperinsulinism 57 rs# [001] 57 pulmonary metastases 57 PLA2 57 Li Fraumeni 57 cMET 57 genetic loci 57 JMML 57 lymphangiogenesis 57 spinal muscular atrophy SMA 57 mood dysregulation 57 carcinoid 57 basal cell nevus syndrome 57 subclinical 57 ductal adenocarcinoma 57 VIPR2 57 sensory neuropathy 57 chronicity 57 cranial irradiation 57 Retinitis Pigmentosa RP 57 Genetic variants 57 choroidal vasculopathy 57 choroidal neovascularization 57 neuron degeneration 56 myeloproliferative disorder 56 autonomic dysfunction 56 interferon γ 56 MEFs 56 PDGF receptor 56 atypical hemolytic uremic syndrome 56 giant cell arteritis 56 STAT4 56 chromosome #p#.# 56 autosomal dominant disorder 56 metastatic prostate 56 FGFR1 56 C1q 56 neurotrophic 56 somatic mutations 56 Estrogen Receptor 56 MELAS 56 phenotype 56 Dilated Cardiomyopathy 56 supratentorial 56 paraganglioma 56 congenital disorders 56 NOTCH1 56 proto oncogene 56 squamous cell carcinoma SCC 56 haematopoietic 56 familial amyloidotic polyneuropathy FAP 56 azacytidine 56 PIK3CA 56 activating mutations 56 TRAS 56 invasive ductal 56 APOE genotype 56 apolipoprotein E4 56 SNP rs# [002] 56 Juvenile Idiopathic Arthritis 56 HeFH 56 amnestic MCI 56 IFN beta 56 serum concentrations 56 Leber Congenital Amaurosis LCA 56 autosomal dominant 56 CD8 + 56 LQTS 56 K#R [002] 56 Acute myeloid leukemia 56 acute myeloid 56 Safinamide 56 LV dysfunction 56 leiomyomas 56 gene polymorphisms 56 lymphocytic 56 pathogenic mechanisms 56 substrate specificity 56 p# mutations 56 isotypes 56 56 ApoE4 56 HBV genotypes 56 polycystic kidneys 56 CagA 56 PTP1B 56 Acidosis 56 Squamous 56 Adrenergic 56 LVNC 56 medullary thyroid carcinoma 56 mineralocorticoid 56 lymphocytosis 56 TNFalpha 56 generalized epilepsy 56 multivariable analysis 56 Aspergillus infections 56 serum albumin 56 Myotonic dystrophy 56 immunoreactivity 56 nondemented 56 ERBB4 56 tumor suppressor protein 56 APOC3 56 macroalbuminuria 56 Critical Limb Ischemia CLI 56 constitutively expressed 56 Pgp 56 lymphoid malignancies 56 p#Kip# 56 gene APOE 56 Beta Thalassemia 56 Rheumatoid 56 Cytochrome P# 56 carcinoids 56 autosomal recessive 56 DNA methylation patterns 56 TT genotype 56 KRAS mutation 56 lymphocytic leukemia 56 androgen deprivation 56 Polymorphisms 56 Glypromate 56 survivin 56 subclinical hypothyroidism 56 Atopic eczema 56 cardiac hypertrophy 56 Polyneuropathy 56 COL#A# 56 ABL1 56 probands 56 albumin excretion 56 Janus Kinase 56 Hashimoto thyroiditis 56 liver metastases 56 chromosome #p# [001] 56 hypomethylation 56 alveolar epithelial cells 56 clusterin 56 Alkaline Phosphatase 56 prostate cancer PCa 56 neuroblastomas 56 renal cysts 56 KIT mutations 56 juvenile idiopathic arthritis JIA 56 adenocarcinomas 56 dysbindin 56 perfusion abnormalities 56 hypovitaminosis D 56 ERK1 2 56 BCL#A 56 LRP5 56 Wiskott Aldrich syndrome 56 BPS IC 56 microsatellite instability 56 atherogenic dyslipidemia 56 experimental allergic encephalomyelitis 56 Fas ligand 56 lymphangioleiomyomatosis LAM 56 beta3 56 androgen receptor AR 56 HLA DRB1 * 56 gefitinib Iressa 56 interferon pathway 56 Severe Asthma 56 hypopituitarism 56 UGT#A# * 56 microcephalin 56 variant allele 56 Haptoglobin 56 genetic polymorphisms 56 EGFR mutant 56 papillary renal cell carcinoma 56 Htt 56 dyskinetic 56 remyelination 56 splenocytes 56 M. pneumoniae 56 NRTI resistance 56 ataxias 56 Epstein Barr Virus 56 SRBD 56 aneuploidies 56 GIST tumors 56 intraventricular 56 cortical activation 56 familial adenomatous polyposis 56 neoplasias 56 IGFBP 3 56 GPx 56 Clusterin 56 bronchial hyperresponsiveness 56 atherosclerotic vascular disease 56 Beta Amyloid 56 alpha synuclein protein 56 neurocognitive deficits 56 acute leukemias 56 Tumor Necrosis Factor 56 proliferative diabetic retinopathy 56 Myelodysplastic Syndrome MDS 56 Enzastaurin 56 Kinoid 56 hematologic disorders 56 mixed hyperlipidemia 56 ectodermal dysplasia 56 STRIDE PD 56 spinocerebellar ataxia 56 A1PI 56 thrombin receptor 56 tau phosphorylation 56 mitochondrial disorders 56 NPHP 56 splice variants 56 Chronic lymphocytic leukemia 56 GNAQ 56 myotonia 56 anterior uveitis 56 seropositivity 56 Malignant Melanoma 56 clinicopathological 56 apolipoprotein E APOE 56 autoantibody levels 56 transgenic mouse models 56 NKX#.# 56 EGFR HER2 56 deletion 5q 56 Prostatitis 56 chromosome #q 56 Neurodegenerative diseases 56 asymptomatic carotid stenosis 56 MGUS 56 Brodmann Area 56 PIGF 56 congenita 56 baseline LDH 56 CNTNAP2 56 sJIA 56 Arrhythmogenic Right Ventricular Cardiomyopathy 56 proteolytic cleavage 56 Parkinson disease PD 56 microdeletion 56 cerebral vasospasm 56 virological response 56 BRCA1 BRCA2 56 CYP#C# * 56 CsA 56 PU.1 56 neuritic 56 hepatic fibrosis 56 antiphospholipid syndrome 55 Sezary syndrome 55 chromosome #p# [002] 55 Apolipoprotein E 55 Iron Overload 55 breast carcinomas 55 advanced adenomas 55 Venous thromboembolism 55 Foxp3 55 SGPT 55 liposomal amphotericin B 55 Meningiomas 55 serous ovarian cancer 55 TPMT 55 susceptibility loci 55 polymyalgia rheumatica 55 HepG2 cells 55 Lafora disease 55 COMT 55 transgenic mouse model 55 Philadelphia Chromosome Positive 55 G6PD deficiency 55 renal cell carcinomas 55 TLR3 55 GBM tumors 55 PC# cells 55 epithelial tumors 55 HER2 expression 55 chronic eosinophilic leukemia 55 lactose malabsorption 55 ependymomas 55 cardiac dysfunction 55 infarcts 55 lung metastasis 55 IFN α 55 TET2 55 chromosomal alterations 55 papillary RCC 55 K#N 55 neutralizing antibody 55 DLC1 55 pleiotropic effects 55 glutamatergic neurons 55 carcinoid tumors 55 transgenic rats 55 ER CHOP 55 pDCs 55 ErbB2 positive 55 castrate resistant 55 juvenile idiopathic arthritis 55 chemoresistant 55 myocardial fibrosis 55 polyposis 55 Fenretinide 55 NNRTI resistant virus 55 hypoperfusion 55 receptor kinase 55 node metastases 55 Acute Lymphoblastic Leukaemia 55 CD# + [001] 55 TMC# r 55 serotonin transporter 55 FDG PET imaging 55 activin 55 parainfluenza virus 55 UCP2 55 Fibrosis 55 ApoE gene 55 liver metastasis 55 telomere lengths 55 adenomyosis 55 CHEK2 55 Janus kinase 55 nonmelanoma skin cancers 55 neurological manifestations 55 mGluRs 55 occipital regions 55 autosomal recessive disease 55 eotaxin 55 castrate resistant prostate cancer 55 hyper IgE syndrome 55 gliosis 55 neuronal dysfunction 55 neuropathologic 55 pituitary adenomas 55 mTOR mammalian target 55 differential gene expression 55 essential thrombocythemia 55 IFN gamma 55 p#NTR 55 underlying pathophysiology 55 paricalcitol 55 alpha1 antitrypsin AAT deficiency 55 eNOS 55 apolipoproteins 55 Chronic Prostatitis 55 Smad3 55 Apolipoprotein 55 urothelial cancer 55 chromosome #q# [002] 55 JAK2 V#F 55 dysfunction LVSD 55 idiopathic PAH 55 endophenotypes 55 urolithiasis 55 TGF ß 55 GH deficiency 55 TEL AML1 55 HIF 1a 55 familial adenomatous polyposis FAP 55 intensive statin therapy 55 thromboses 55 intestinal permeability 55 aurora kinase 55 metastatic carcinoid tumors 55 P2X 55 spondyloarthritis 55 IL 7R 55 inherited mutations 55 cytokine signaling 55 pancreatectomy 55 bcl 2 55 vasospasm 55 acute lymphoid leukemia 55 isolated systolic hypertension 55 EBV infection 55 downregulated 55 OGG1 55 CCR7 55 uricase 55 chromosome abnormality 55 pretransplant 55 tau pathology 55 hyperresponsiveness 55 Adenomas 55 MDR1 55 neoplastic 55 myofascial pain syndrome 55 FGFR3 55 cytopenias 55 SNP rs# [001] 55 db db mice 55 IGFBP 55 NTx 55 IIIb 55 atopic 55 Cholangiocarcinoma 55 retinitis pigmentosa RP 55 IgA deficiency 55 murine models 55 mucinous 55 cervical lymph nodes 55 mesotheliomas 55 LV ejection fraction 55 glioblastoma tumors 55 hepatorenal syndrome 55 del 5q 55 ARVD 55 aminotransferase 55 synaptogenesis 55 hypothalamic pituitary 55 colorectal liver metastases 55 intermittent hypoxia 55 Fibromyalgia syndrome 55 CYP#D# 55 c KIT 55 TEVAR 55 serum calcium levels 55 transcranial Doppler ultrasound 55 TP# mutations 55 vidofludimus 55 amyloid deposition 55 serpin 55 CYP# [002] 55 acute coronary syndromes ACS 55 physiologic mechanisms 55 hyperglycaemia 55 idiopathic thrombocytopenic purpura 55 pancreatic endocrine 55 Acute Renal Failure 55 acute GvHD 55 clobazam 55 Duchenne Muscular Dystrophy DMD 55 hepatocellular carcinoma HCC 55 dopaminergic 55 histologically proven 55 NOD mouse 55 de novo AML 55 ximelagatran 55 renal tumors 55 CD#c 55 PEGylated interferon beta 1a 55 thoracic aortic disease 55 CALHM1 55 lymphoproliferative disorders 55 LRRK2 mutation 55 gallstone disease 55 atherothrombotic disease 55 #β estradiol 55 aortic root replacement 55 APOL1 55 IL6 55 Fludarabine 55 EGFRvIII 55 comorbid anxiety 55 tumoral 55 hepatic cirrhosis 55 alpha2 55 Peutz Jeghers syndrome 55 spontaneous remission 55 HBsAg 55 GPC5 55 T#M 55 PTEN gene 55 somatoform disorders 55 Transgenic Mice 55 EGFR tyrosine kinase inhibitors 55 ANCA associated 55 colorectal adenoma 55 Waldenstrom macroglobulinemia 55 Adjuvant therapy 55 AT1R 55 MMP9 55 receptor tyrosine kinase inhibitor 55 Overexpression 55 depsipeptide 55 #q# [001] 55 arterial calcification 55 SGS# 55 CYP#C# [001] 55 SCN5A 55 PNET 55 Non inferiority 55 systolic hypertension 55 cisplatin resistant 55 baroreflex 55 haematologic 55 histological subtype 55 GW# [003] 55 leukocyte count 55 TIMP 55 CSF biomarkers 55 transthyretin amyloidosis 55 hypermethylated 55 immunoreactive 55 Systemic Lupus Erythematosus 55 S#A# [002] 55 biochemical relapse 55 monozygotic twin 55 antiproliferative activity 55 perioperative complications 55 syntaxin 55 inflammatory demyelinating 55 atypical parkinsonism 55 PTLD 55 cerebral microbleeds 55 TNF α 55 metalloprotease 55 IL#R 55 hypercholesterolaemia 55 missense mutation 55 lesional 55 hyperalgesia 55 neuropsychiatric diseases 55 FMR1 gene 55 circadian clock genes 55 premorbid 55 ataxia telangiectasia 55 Chronic pancreatitis 55 overt hypothyroidism 55 heterozygote 55 Cardiotoxicity 55 dopamine signaling 55 Etanercept 55 subependymal giant cell 55 NSCLC tumors 55 receptor antagonists 55 PD# [005] 55 Dysplasia 55 von Willebrand 55 causal variants 55 pancreatic neuroendocrine tumors 55 TIMP 1 55 Tyrosine Kinase Inhibitor 55 thymoma 55 immunostaining 55 graft dysfunction 55 autoimmune thyroiditis 55 nitrotyrosine 55 annexin 55 renal scarring 55 isoprostane 55 MVA MUC1 IL2 55 elevated triglyceride levels 55 aMCI precursor 55 monocytes macrophages 55 Myeloid 55 Annexin 55 myopathies 55 #beta HSD1 55 Anaplastic 55 interstitial pneumonia 55 affective psychoses 54 adriamycin 54 apoE 54 hypophosphatasia 54 amyloid β 54 variceal bleeding 54 neuropsychological impairments 54 thrombocytopenic 54 diabetes mellitus T2DM 54 Gorlin syndrome 54 bronchogenic carcinoma 54 cryptogenic stroke 54 extrapyramidal symptoms 54 unresectable stage 54 β2 54 Retinoblastoma 54 Posiphen 54 ventricular myocardium 54 inhaled corticosteroid therapy 54 TGF ß1 54 plasma folate 54 Cardiac Troponin 54 Ataluren 54 diagnostic biomarker 54 Troponin T 54 promoter polymorphism 54 isoenzyme 54 azoospermia 54 MetS 54 aortic valve stenosis 54 congenital adrenal hyperplasia CAH 54 H#K#me# 54 ON #.Na 54 renal artery stenosis 54 Myopathy 54 cirrhotic 54 neurocognitive function 54 busulfan 54 infantile hemangioma 54 papillary thyroid carcinoma 54 CYP #D# 54 mGluR2 NAM 54 5q 54 canakinumab 54 nonalcoholic steatohepatitis NASH 54 bulbar 54 autoregulation 54 periventricular 54 IL #R 54 Lenalidomide 54 PPCM 54 Frontotemporal Dementia 54 efalizumab 54 polyarticular 54 leiomyoma 54 Prognostic factors 54 ERalpha 54 Mild Cognitive Impairment 54 GSTT1 54 UGT#A# 54 Nephrotic Syndrome 54 Symadex 54 recurrent VTE 54 MLL2 54 Angiotensin II 54 Papillary 54 COMT enzyme 54 desmoplastic 54 antitrypsin 54 Purkinje cell 54 FXTAS 54 IgG4 54 α KG 54 Inflammatory bowel disease 54 autosomal recessive genetic 54 interleukin IL -# 54 Combination therapy 54 receptor inhibitor 54 intact parathyroid hormone 54 hepatoma 54 total thyroidectomy 54 hereditary spastic paraplegia 54 hypereosinophilic syndrome 54 hereditary hemorrhagic telangiectasia 54 QRS interval 54 thyroglobulin 54 tumor necrosis 54 constipation predominant irritable bowel 54 costimulatory 54 Eisenmenger syndrome 54 Oesophageal 54 pT2 54 TGFβ 54 Hepatocellular Carcinoma HCC 54 intestinal mucosal 54 homozygous FH 54 Catenin 54 cutaneous squamous cell carcinoma 54 5alpha reductase 54 OPRM1 gene 54 APOE gene 54 C. pneumoniae 54 phosphorylase 54 paralogs 54 MnSOD 54 NOD SCID mice 54 TGFBR1 * 6A 54 CLL SLL 54 S. maltophilia 54 relapsed ALL 54 EGFR inhibition 54 dyslipidaemia 54 receptor antagonism 54 sarcomatoid 54 LHRH agonists 54 CIMZIA ™ 54 androgen receptor gene 54 #q#.# [002] 54 malignant pleural mesothelioma 54 neovascularization 54 mGlu2 3 54 adrenalectomy

Back to home page